期刊文献+

强阿片类药物治疗癌性疼痛的临床研究 被引量:15

Clinical observation of strong opioid drugs for pain cased by cancer
原文传递
导出
摘要 目的:评价强阿片类药物治疗中、重度癌痛的疗效及安全性,探讨镇痛治疗对生活质量和预后的影响。方法:应用强阿片类药物治疗伴有中、重度疼痛的恶性肿瘤患者122例,观察药物剂量、疗效、不良反应及生存期;采用生活质量量表EORTCQLQ-C30(V3.0)中文版评估66例肺癌疼痛患者镇痛前后的生活质量变化,并对不同疼痛程度和不同疼痛缓解程度癌痛患者的预后进行比较分析。结果:使用阿片类药物治疗后,中度、重度疼痛患者疼痛缓解率分别为94.9%和86.7%;与治疗前相比疼痛程度明显减低,P<0.05。治疗过程中便秘发生率47.5%、恶心呕吐11.5%、排尿困难9.0%、头晕4.9%。经镇痛治疗后91.4%的患者生活质量明显改善,尤以失眠改善最为明显。Kaplan-Meier生存分析显示,中度癌痛患者半年总疼痛治疗生存率明显优于重度疼痛者,疼痛程度与生存显著相关,P=0.000。疼痛完全缓解和明显缓解者半年总疼痛治疗生存率明显高于中度和轻度缓解者,疼痛缓解程度与生存显著相关,P=0.003。Cox多因素分析结果显示,疼痛部位和疼痛程度是影响预后的独立危险因素。结论:强阿片类药物治疗中、重度癌性疼痛是安全有效的;它能明显提高癌痛患者生存率、延长其生存期,并能提高肺癌癌痛患者的生活质量。 OBJECTIVE:To evaluate the efficacy and safety of strong opioid drugs in patients with moderate-severe cancer pain,and observe the improvement of quality of life(QOL) and prognosis.METHODS:Totally 122 cases of patients who were diagnosed with pathology were selected.All of them had complaints of pain(NRS score for moderate-severe pain),and were treated with strong opioid.The onset time,efficacy,adverse reactions and surcival time were observed.QOL were assessed in 66 lung cancer patients,using EORTC QLQ-C30(V3.0),as well as the different level of pain,cancer pain and pain relief in patients with different prognosis were analyzed.RESULTS:Pain in patients with moderate pain relief rate was 94.9%,and with severe pain remission rate was 86.7%.With the degree of pain before treatment was significantly lower(P0.05).The common side effects were constipation(47.5%),nausea and vomitting(11.5%),dysuria(9.0%),dizziness(4.9%).The course of the study found no respiratory depression,mental or physical dependence on the adverse reactions.And 91.4% of patients had improved quality of life.Kaplan-Meier survival analysis showed that patients with moderate pain for six months survival rate was significantly better than the overall treatment of pain with severe pain and pain level was significantly correlated with survival(P=0.000).Complete remission of pain and obvious pain remission for six months the total survival rate was significantly higher than moderate and mild remission,pain relief was significantly correlated with survival(P=0.003).Cox multivariate analysis showed that the pain area and pain level is an independent prognostic risk factors.CONCLUSIONS:The strong opioid treatment of moderate and severe cancer pain is safe and effective.It markedly improved the survival rate in patients with cancer pain and prolong the survival period,and can improve the quality of life in patients with lung cancer pain.
作者 倪楠 许崇安
出处 《中华肿瘤防治杂志》 CAS 2010年第22期1874-1877,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 强阿片类 癌痛 生活质量 生存期 strong opioid drugs Cancer pain Quality of life Survival time
  • 相关文献

参考文献9

  • 1Arcuri E, Ginobbi P. Tirelli W, et al. Preliminary in vivo experimental evidence on intratumoral morphine uptake. Possible clinical implications in cancer pain and opioid pesponsiveness[J]. Pain Symptom Manage, 2002, 24(1): 1-3. 被引量:1
  • 2万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1283
  • 3邹建军,郑莹,曹传武,骆益宙,李荣,钱建新,王杰军.疼痛对癌症患者抑郁和生活质量影响的研究[J].癌症进展,2004,2(5):356-360. 被引量:24
  • 4Kohda R, Otsubo T, Kuwakado Y, et al. Prospective studies on mental status and quality of life in patient s with head and neck cancer treated by radiation[J]. Psychooneology, 2005,14(4):331-336. 被引量:1
  • 5Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site[J]. Psychooncology, 2001,10(1):19-28. 被引量:1
  • 6Koizumi W,Toma H,Watanabe K, et al. Efficacy and tolerability of cancer pain management with controlled release oxycodone tablets in opioid-naive cancer pain patients, starling with 5mg tablets[J]. Jpn J Clin Oncol, 2004, 34(10): 608-614. 被引量:1
  • 7于世英,邱红,马振山,陈嘉,张英,陈立正,王东林,马智勇.盐酸吗啡缓释片治疗癌症疼痛的临床疗效分析[J].中华医学杂志,2004,84(6):450-455. 被引量:33
  • 8Fillingim R B, Gear R W. Sex differences in opioid analgesia: clinical and experimental findings[J]. Eur J Pain, 2004, 8(5): 413-425. 被引量:1
  • 9Sarton E, Olofsen E, Romberg R, et al. Sex differences in morphine analgesia: an experimental study in healthy volunteers[J]. Anesthesiology, 2000, 93(5): 1245-1254. 被引量:1

二级参考文献22

  • 1[1]Clara LMY, Richard F, Cecelia LWC, et al. Measuring quality of life of Chinese cancer patients. A validation of the Chinese version of the functional assessment of cancer therapy - general (FACT-G) scale. Cancer, 2000, 88 (7) :1715 被引量:1
  • 2[4]Zabora J, Brintzenhofe Szoc K, Crubow B, et al. The prevalence of psychological distress by cancer site. Psychooncology,2001, 10 (1) :19 被引量:1
  • 3[5]Christine Zaza, Natalie Baine. Cancer pain and psychosocial factors: A critical review of the literature. Journal of Pain and Symptom Management, 2002, 24 (5) :526 被引量:1
  • 4[6]Kai-hoiSzeF, WongE, Lo R, etal. Do pain and disability differ in depressed cancer patients?. Palliative Medicine, 2000,14 (1) :11 被引量:1
  • 5[7]Lani Zimmerman, Kristine TS, Fannie GJ et al. Psychological variables and cancer pain. Cancer Nursing, 1996, 19 (1) :44 被引量:1
  • 6[8]Ciaramella A, Poli P. Assessment of depression among caner type and treatment. Psychooncology, 2001, 10 (2) :156 被引量:1
  • 7[9]Ozalp G, Sarioglu R, Tuncel G, et al. Preoperative emotional states inpatients with breast cancer and postoperative pain. Acta Anaesthesiol Scand, 2003, 47 (1) : 26 被引量:1
  • 8Johnson JR,Temple R. Food and drug administration requirements for approval of new anti-cancer drugs[J]. Cancer Treat Rep, 1985,69(10) : 1155-1157. 被引量:1
  • 9Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30:a quality of life instrument for use in international clinical trials in oncology [J]. J Natl Cancer Inst, 1993,85 (5) : 365-376. 被引量:1
  • 10Aaronson NK, Cull A, Kaasa S, et al. The EORTC modular approach to quality of life assessment in ontology [J]. Int J Ment Health, 1994,23 (4):75-96. 被引量:1

共引文献1334

同被引文献105

引证文献15

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部